In this episode of the Scope of Things, host Deborah Borfitz delivers the latest on an AI-powered trial screening tool that outperforms research staff, a strategy report on ways to boost cancer vaccine work, the continued absence of pregnant women in clinical trials, a program bringing studies directly to people in rural Utah, and efforts to integrate clinical trials into routine patient care in medically underserved areas of Oklahoma. Wes Michael, founder and president of Rare Patient Voice, also joins in to discuss how his company is connecting people undertaking research studies with participants eager to share their insights—and getting paid to do so.

News Roundup

AI clinical trial screening tool

• Research letter in JAMA

Strategy report on cancer vaccines

• Commentary in Cambridge Prisms: Precision Medicine

Exclusion of pregnant women from trials

• Article in American Journal of Obstetrics and Gynecology

Bringing cancer care and trials to Utah’s rural residents

• Press release on Huntsman Cancer Institute website

Integrating clinical research into primary care

• News on OU Health Sciences website

Guest

Wes Michael, president and founder of Rare Patient Voice

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.